MetLife Financing Receivables decreased by 1.0% to $83.69B in Q1 2026 compared to the prior quarter. Over 2 years (FY 2020 to FY 2025), Financing Receivables shows relatively stable performance with a 0.4% CAGR.
Growth generally signals expansion of the lending business, while a decline may indicate contraction or a shift in capital allocation strategy.
Financing receivables represent the aggregate contractual amounts due from customers arising from lending and leasing ac...
Standard metric across all commercial and retail banking institutions.
financing_receivables| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|
| Value | $80.96B | $79.35B | $79.97B | $82.03B | $82.44B | $84.56B | $83.69B |
| QoQ Change | — | -2.0% | +0.8% | +2.6% | +0.5% | +2.6% | -1.0% |
| YoY Change | — | — | — | — | +1.8% | — | — |